Convulsive Disorders

The Mouse in Biomedical Research

Volumn 3, Issue , 2007, Pages 565-594

  Todorova, Mariana T ^a   Seyfried, Thomas N ^a  

^a BOSTON COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884465389     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369454-6/50071-6     Document Type: Chapter

References (367)

1. Aizawa M., Ito Y, Fukuda H. Pharmacological profiles of generalized absence seizures in lethargic, stargazer and gamma-hydroxybutyrate-treated model mice. Neurosci Res 1997, 29:17-25.
2. Alakurtti K., Virtaneva K., Joensuu T., Palvimo J.J., Lehesjoki A.E. Characterization of the cystatin B gene promoter harboring the dodecamer repeat expanded in progressive myoclonus epilepsy, EPM1. Gene 2000, 242:65-73.
3. Alexander G.J., Meltzer H.L. Onset of audiogenic seizures in rodents after intake of near-toxic doses of rubidium chloride. J Pharmacol Exp Ther 1975, 194:480-487.
4. Andermann E. Multifactorial inheritance of generalized and focal epilepsy. Genetic basis of epilepsies 1982, 355-376. Raven Press, New York.
5. Anderson E., Berkovic S., Dulac O., Gardiner M., Jain S., Laue Friis M., et al. ILAE genetics commission conference report: molecular analysis of complex genetic epilepsies. Epilepsia 2002, 43:1262-1267.
6. Anisman H., Zaharia M.D., Meaney M.J., Merali Z. Do early-life events permanently alter behavioral and hormonal responses to Stressors?. Int JDev Neurosci 1998, 16:149-164.
7. Applegate C.D., Tecott L.H. Global increases in seizure susceptibility in mice lacking 5-HT2C receptors: a behavioral analysis. Exp Neurol 1998, 154:522-530.
8. Bac P., Pages N., Herrenknecht C., Dewulf C., Binet P., Durlach J. Effect of various serotoninergically induced manipulations on audiogenic seizures in magnesium-deficient mice. Magnes Res 1994, 7:107-115.
9. Banfi S., Servadio A., Chung M.Y, Kwiatkowski T.J., Mccall A.E., Duvick L.A., et al. Identification and characterization of the gene causing type 1 spinocerebellar ataxia. Nat Genet 1994, 7:513-520.
10. Banko M.L., Allen K., Dolina S., Neumann P.E., Seyfried T.N. Genomic imprinting and audiogenic seizures in mice. Behav Genet 1997, 27:465-475.
11. Baraban S.C., Hollopeter G., Erickson J.C., Schwartzkroin P.A., Palmiter R.D. Knock-out mice reveal a critical antiepileptic role for neuropeptide Y. J Neurosci 1997, 17:8927-8936.
12. Barlow D.R Gametic imprinting in mammals. Science 1995, 270:1610-1613.
13. Baulac S., Huberfeld G., Gourfinkel-an I., Mitropoulou G., Beranger A., Prud'homme J.F., et al. First genetic evidence of GABA (A) receptor dysfunction in epilepsy: a mutation in the gamma2-subunit gene. Nat Genet 2001, 28:46-48.
14. Bayer S.A., Wills K.V., Triarhou L.C., Verina T., Thomas J.D., Ghetti B. Selective vulnerability of late-generated dopaminergic neurons of the substantia nigra in weaver mutant mice. Proc Natl Acad Sci U S A 1995, 92:9137-9140.
15. Bell S.M., Schreiner C.M., Schultheis P.J., Miller M.L., Evans R.L., Vorhees C.V., et al. Targeted disruption of the murine Nhel locus induces ataxia, growth retardation, and seizures. Am J Physiol 1999, 276:C788-C795.
16. Ben-Ari Y Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 1985, 14:375-403.
17. Berkovic S.F., Andermann F., Carpenter S., Wolfe L.S. Progressive myoclonus epilepsies: specific causes and diagnosis. N Engl J Med 1986, 315:296-305.
18. Berkovic S.F., Heron S.E., Giordano L., Marini C., Guerrini R., Kaplan R.E., et al. Benign familial neonatal-infantile seizures: characterization of a new sodium channelopathy. Ann Neurol 2004, 55:550-557.
19. Birnbaumer L., Qin N., Olcese R., Tareilus E., Platano D., Costantin J., Stefani E. Structures and functions of calcium channel beta subunits. J Bioenerg Biomembr 1998, 30:357-375.
20. Bonasera S.J., Tecott L.H. Mouse models of serotonin receptor function: toward a genetic dissection of serotonin systems. Pharmacol Ther 2000, 88:133-142.
21. Bond TL., Drage M., Heinrichs S.C Scizure-prone EL mice exhibit deficits in pup nursing and retrieval assessed using a novel method of maternal behavior phenotyping. Epilepsy Behav 2003, 4:57-64.
22. Boyd S.G., Harden A., Patton M.A. The EEG in early diagnosis of the Angelman (happy puppet) syndrome. Eur J Pediatr 1988, 147:508-513.
23. Brennan T.J., Seeley W.W, Kilgard M., Schreiner C.E., Tecott L.H. Sound-induced seizures in serotonin 5-HT2c receptor mutant mice. Nat Genet 1997, 16:387-390.
24. Brennan T.J., Seeley W.W., Kilgard M., Schreiner C.E., Tecott L.H. Sound-induced seizures in serotonin 5-HT2c receptor mutant mice. Nat Genet 1997, 16:387-390.
25. Brigande J.V., Wieraszko A., Albert M.D., Balkema G.W., Seyfried T.N. Biochemical correlates of epilepsy in the El mouse: analysis of glial fibril-lary acidic protein and gangliosides. J. Neurochem 1992, 58:752-760.
26. Browne T.R., Holmes G.L. Epilepsy. N Engl J Med 2001, 344:1145-1151.
27. Browning R.A., Hoffmann W.E., Simonton R.L. Changes in seizure susceptibility after intracerebral treatment with 5,7-dihydroxytryptamine: role of serotonergic neurons. Ann N YAcad Sci 1978, 305:437-456.
28. Buck K.J., Rademacher B.S., Metten P., Crabbe J.C. Mapping murine loci for physical dependence on ethanol. Psychopharmacology (Berl) 2002, 160:398-407.
29. Buhot M.C. Serotonin receptors in cognitive behaviors. Curr Opin Neurobiol 1997, 7:243-254.
30. Buiting K., Saitoh S., Gross S., Dittrich B., Schwartz S., Nicholls R.D., Horsthemke B. Inherited microdeletions in the Angelman and Prader-Willi syndromes define an imprinting centre on human chromosome 15. Nat Genet 1995, 9:395-400.
31. 2+ channel gamma subunit genes on chromosome 19ql3.4: evolution and expression profile of the gamma subunit gene family. Genomics 2001, 71:339-350.
32. 2+ channel beta subunit gene Cchb4 is associated with ataxia and seizures in the lethargic (lh) mouse. Cell 1997, 88:385-392.
33. Burgess D.L., Noebels J.L. Voltage-dependent calcium channel mutations in neurological disease. Ann N YAcad Sci 1999, 868:199-212.
34. Campbell D.B., Hess E.J. L-type calcium channels contribute to the tottering mouse dystonic episodes. Mol Pharmacol 1999, 55:23-31.
35. 2+ channels and snare pro-teins in neurotransmitter release. Ann N YAcad Sci 1999, 868:144-159.
36. Caviness V.S., Rakic P. Mechanisms of cortical development: a view from mutations in mice. Annu Rev Neurosci 1978, 1:297-326.
37. Chae T., Kwon Y.T., Bronson R., Dikkes P., Li E., Tsai L.H. Mice lacking p35 a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron 1997, 18:29-42.
38. Chan E.M., Bulman D.E., Paterson A.D., Turnbull J., Andermann E., Andermann F., et al. Genetic mapping of a new Lafora progressive myoclonus epilepsy locus (EPM2B) on 6p22. J Med Genet 2003, 40:671-675.
39. Chan E.M., Omer S., Ahmed M., Bridges L.R., Bennett C., Scherer S.W., Minassian B.A. Progressive myoclonus epilepsy with polyglucosans (Lafora disease): evidence for a third locus. Neurology 2004, 63:565-567.
40. Chan E.M., Young E.J., Ianzano L., Munteanu I., Zhao X., Christopoulos C.C., et al. Mutations in NHLRC1 cause progressive myoclonus epilepsy. Nat Genet 2003, 35:125-127.
41. Chang C., Smith D.R., Prasad VS., Sidman C.L., Nebert D.W., Puga A. Ten nucleotide differences, five of which cause amino acid changes, are associated with the Ah receptor locus polymorphism of C57BL/6 and DBA/2 mice. Pharmacogenetics 1993, 3:312-321.
42. Chen L., Chetkovich D.M., Petralia R.S., Sweeney N.T., Kawasaki Y., Wenthold R.J., Bredt D.S., Nicoll R.A. Stargazin regulates synap-tic targeting of AMPA receptors by two distinct mechanisms. Nature 2000, 408:936-943.
43. Clark S., Wilson W.A. Mechanisms of epileptogenesis. Adv Neurol 1999, 79:607-630.
44. Compan V, Zhou M., Grailhe R., Gazzara R.A., Martin R., Gingrich J., et al. Attenuated response to stress and novelty and hypersensitivity to seizures in 5-HT4 receptor knock-out mice. J Neurosci 2004, 24:A2-A9.
45. Cooper E.M., Hudson A.W., Amos J., Wagstaff J., Howley P.M. Biochemical analysis of Angelman syndrome-associated mutations in the E3 ubiquitin ligase E6-associated protein (E6AP) . J. Biol Chem 2004, 279(39):41208-41217.
46. Cox G.A., Lutz C.M., Yang C.L., Biemesderfer D., Bronson R.T., Fu A., et al. Sodium/hydrogen exchanger gene defect in slow-wave epilepsy mutant mice. Cell 1997, 91:139-148.
47. Crunelli V, Leresche N. Childhood absence epilepsy: genes, channels, neurons and networks. Nat Rev Neurosci 2002, 3:371-382.
48. Daikhin Y, Yudkoff M. Ketone bodies and brain glutamate and G AB A metabolism. Dev Neurosci 1998, 20:358-364.
49. Delgado-Escueta A.V, Ganesh S., Yamakawa K. Advances in the genetics of progressive myoclonus epilepsy. Am J Med Genet 2001, 106:129-138.
50. Delorey T.M., Handforth A., Anagnostaras S.G., Homanics G.E., Minassian B.A., Asatourian A., et al. Mice lacking the beta3 subunit of the G AB AA receptor have the epilepsy phenotype and many of the behav-ioral characteristics of Angelman syndrome. J Neurosci 1998, 18:8505-8514.
51. DeLorey T.M., Olsen R.W. GABA and epileptogenesis: comparing gabrb3 gene-deficient mice with Angelman syndrome in man. Epilepsy Res 1999, 36:123-132.
52. Devivo D.C., Leckie M.P., Ferrendelli J.S., Mcdougal D.B. Chronic ketosis and cerebral metabolism. Ann Neurol 1978, 3:331-337.
53. Dirocco L., Dalton T., Liang D., Nebert D.W., Seyfried T.N. Nonallelism for the audiogenic seizure prone (Aspl) and the arylhydrocar-bon receptor (Ahr) loci in mice. J. Neurogenetics 1998, 12:191-203.
54. Dlouhy S.R., Richter J., Stauss C.J.W., Hodes M.E., Ghetti B. Introduction of the weaver gene onto the BALB/cJ strain. Soc Neurosci (Abst) 1996, 22:1649.
55. Dolina S., Keller A., Morin C., Ribak C.E. Structural and GABAergic abnormalities in the epileptic brain of an inbred substrain of BALB/c mice. Epilepsia 1992, 33:41-42.
56. Dolina S., Peeling J., Sutherland G., Pillay N., Greenberg A. Effect of sustained pyridoxine treatment on seizure susceptibility and regional brain amino acid levels in genetically epilepsy-prone BALB/c mice. Epilepsia 1993, 34:33-42.
57. Donner E.J., Smith C.R., Snead O.C.3rd. Sudden unexplained death in children with epilepsy. Neurology 2001, 57:430.
58. Donovan G.P., Harden C., Gal J., Ho L., Sibille E., Trifiletti R., et al. Sensitivity to jerky gene dosage underlies epileptic seizures in mice. J Neurosci 1997, 17:4562-4569.
59. Doyle J., Ren X., Lennon G., Stubbs L. Mutations in the Cacnlla4 calcium channel gene are associated with seizures, cerebellar degeneration, and ataxia in tottering and leaner mutant mice. Mamm Genome 1997, 8:113-120.
60. Drage M.G., Holmes G.L., Seyfried T.N. Hippocampal neurons and glia in epileptic EL mice. J Neurocytol 2002, 31:681-692.
61. Efstratiadis A. Parental imprinting of autosomal mammalian genes. Curr Opin Genet Dev 1994, 4:265-280.
62. Eisenberg B., Messer A. Tonic/clonic seizures in a mouse mutant carrying the weaver gene. Neurosci Lett 1989, 96:168-172.
63. Eldridge R., Iivanainen M., Stern R., Koerber T., Wilder B.J. quot;Baltic quot; myoclonus epilepsy: hereditary disorder of childhood made worse by pheny-toin. Lancet 1983, 2:838-842.
64. Engel J.Jr. Classification of epileptic disorders. Epilepsia 2001, 42:316.
65. Engel J.Jr. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001, 42:796-803.
66. Engstrom F.L., Woodbury D.M. Scizure susceptibility in DBA and C57 mice: the effects of various convulsants. Epilepsia 1988, 29:389-395.
67. Erickson J.C., Clegg K.E., Palmiter R.D. Sensitivity to leptin and sus-ceptibility to seizures of mice lacking neuropeptide Y. Nature 1996, 381:415-421.
68. Ericsson M., Poston W.S., Foreyt J.P Common biological pathways in eating disorders and obesity. Addict Behav 1996, 21:733-743. 2nd.
69. Erway L.C., Willott J.F., Archer J.R., Harrison D.E. Genetics of age-related hearing loss in mice. I. Inbred and Fl hybrid strains. Hear Res 1993, 65:125-132.
70. Escayg A., De Waard M., Lee D., Bichet D., Wolf P., Mayer T., et al. Coding and noncoding variation of the human calcium-channel beta4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia. Am J Hum Genet 2000, 66:1531-1539.
71. Escayg A., Heils A., Macdonald B.T., Haug K., Sander T, Meisler M.H. A novel SCN1A mutation associated with generalized epilepsy with febrile seizures plus-and prevalence of variants in patients with epilepsy. Am J Hum Genet 2001, 68:866-873.
72. Eunson L.H., Rea R., Zuberi S.M., Youroukos S., Panayiotopoulos C.R, Liguori R., et al. Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability. Ann Neurol 2000, 48:647-656.
73. Faherty C.J., Xanthoudakis S., Smeyne R.J. Caspase-3-dependent neuronal death in the hippocampus following kainic acid treatment. Brain Res Mol Brain Res 1999, 70:159-163.
74. Feldman R.G., Paul N.L. Identity of emotional triggers in epilepsy. J. Nerv. Ment. Dis. 1976, 162:345-353.
75. 2+ channel physiology and disease etiology. Cell Mol Neurobiol 2002, 22:103-120.
76. Feller DJ., Bassir J.M., Crabbe J.C., Le Fevre C.A. Audiogenic seizure susceptibility in WSP and WSR mice. Epilepsia 1994, 35:861-867.
77. Ferraro T.N., Golden G.T., Smith G.G., Berrettini W.H. Differential susceptibility to seizures induced by systemic kainic acid treatment in mature DBA/2J and C57BL/6J mice. Epilepsia 1995, 36:301-307.
78. Ferraro T.N., Golden G.T., Smith G.G., Demuth D., Buono R.J., Berrettini W.H. Mouse strain variation in maximal electroshock seizure threshold. Brain Res 2002, 936:82-86.
79. Ferraro T.N., Golden G.T., Smith G.G., Longman R.L., Snyder R.L., Demuth D., et al. Quantitative genetic study of maximal elec-troshock seizure threshold in mice: evidence for a major seizure susceptibility locus on distal chromosome 1. Genomics 2001, 75:35-42.
80. Ferraro T.N., Golden G.T., Smith G.G., Martin J.F., Lohoff F.W., Gieringer T.A., et al. Fine mapping of a seizure susceptibility locus on mouse Chromosome 1: nomination of Kcnj 10 as a causative gene. Mamm Genome 2004, 15:239-251.
81. Ferraro T.N., Golden G.T., Smith G.G., Schork N.J., St.Jean P., Ballas C., et al. Mapping murine loci for seizure response to kainic acid. Mamm Genome 1997, 8:200-208.
82. Ferraro T.N., Golden G.T., Smith G.G., St Jean P., Schork N.J., Mulholland N., et al. Mapping loci for pentylenetetrazol-induced seizure susceptibility in mice. JNeurosci 1999, 19:6733-6739.
83. Ferraro T.N., Golden G.T., Snyder R., Laibinis M., Smith G.G., Buono R.J., Berrettini W.H. Genetic influences on electrical seizure threshold. Brain Res 1998, 813:207-210.
84. Flavin H.J., Seyfried T.N. Enhanced aspartate release related to epilepsy in (EL) mice. J Neurochem 1994, 63:592-595.
85. Flavin H.J., Wieraszko A., Seyfried T.N. Enhanced aspartate release from hippocampal slices of epileptic (El) mice. J Neurochem 1991, 56:1007-1011.
86. Fletcher C.F., Frankel W.N. Ataxic mouse mutants and molecular mechanisms of absence epilepsy. Hum Mol Genet 1999, 8:1907-1912.
87. Fletcher C.F., Lutz C.M., Tn O.S., Shaughnessy J.D., Hawkes R., Frankel W.N., et al. Absence epilepsy in tottering mutant mice is associated with calcium channel defects. Cell 1996, 87:607-617.
88. Frankel W.N., Taylor B.A., Noebels J.L., Lutz C.M. Genetic epilepsy model derived from common inbred mouse strains. Genetics 1994, 138:481-4489.
89. Frankel W.N., Taylor L., Beyer B., Tempel B.L., White H.S. Electroconvulsive thresholds of inbred mouse strains. Genomics 2001, 74:306-312.
90. Frankel W.N., Valenzuela A., Lutz C.M., Johnson E.W., Dietrich WE, Coffin J.M. New seizure frequency QTL and the complex genetics of epilepsy in EL mice. Mamm Genome 1995, 6:830-838.
91. Frankel W.N., Valenzuela A., Lutz C.M., Johnson E.W., Dietrich WE, Coffin J.M. New seizure frequency QTL and the complex genetics of epilepsy in EL mice. Mamm. Genome 1995, 6:830-838.
92. Frings H., Frings M., Hamilton M. Experiments with albino mice from stocks selected for predictable susceptibilities to audiogenic seizures. Int J Behav Res 1956, 9:44-53.
93. Fueta Y, Kawano H., Ono T., Mita T., Fukata K., Ohno K. Regional differences in hippocampal excitability manifested by paired-pulse stimulation of genetically epileptic El mice. Brain Res 1998, 779:324-328.
94. Fueta Y, Matsuoka S., Mita T. Crossbreeding analysis of the mouse epilepsy. Sangyo Ika Daigaku Zasshi 1986, 20:417.
95. Fueta Y, Mita T., Matsuoka S. Experimental animal epilepsy: a new device for the induction of epileptic seizures in the murine, El mouse. Sangyo Ika Daigaku Zasshi 1983, 5:359-364.
96. Fueta Y, Schwarz W, Ohno K., Endo Y, Mita T. Selective suppres-sion of hippocampal region hyperexcitability related to seizure susceptibility in epileptic El mice by the GABA-transporter inhibitor tiagabine. Brain Res 2002, 947:212-217.
97. Fueta Y, Vasilets L.A., Takeda K., Kawamura M., Schwarz W. Down-regulation of GABA-transporter function by hippocampal translation products: its possible role in epilepsy. Neuroscience 2003, 118:371-378.
98. Fuller J.L. Independence of inherited susceptibility to spontaneous and primed audiogenic seizures in mice. Behav Genet 1975, 5:1-8.
99. Fuller J.L., Collins R.L. Temporal parameters of sensitization for audiogenic seizures in SJL/J mice. Dev Psychobiol 1968, 1:185-188.
100. Fuller J.L., Sjursen F.H. Audiogenic seizures in eleven mouse strains. JHered 1967, 58:135-140.
101. Ganesh S., Agarwala K.L., Ueda K., Akagi T., Shoda K., Usui T., et al. Laforin, defective in the progressive myoclonus epilepsy of Lafora type, is a dual-specificity phosphatase associated with polyribosomes. Hum Mol Genet 2000, 9:2251-2261.
102. Ganesh S., Delgado-Escueta A.V., Sakamoto T., Avila M.R., Machado-Salas J., Hoshii Y, et al. Targeted disruption of the Epm2a gene causes for-mation of Lafora inclusion bodies, neurodegeneration, ataxia, myoclonus epilepsy and impaired behavioral response in mice. Hum Mol Genet 2002, 11:1251-1262.
103. Ganesh S., Suzuki T., Yamakawa K. Alternative splicing modulates subcellular localization of laforin. Biochem Biophys Res Commun 2002, 291:1134-1137.
104. Ginsburg B. Genetic parameters in behavioral research. Behavior-genetic analysis 1967, 135-153. McGraw Hill, New York. J. Hirsch (Ed.).
105. Goodman WK. Obsessive-compulsive disorder: diagnosis and treatment. J. Clin Psychiatry 1999, 60(Suppl 18):27-32.
106. Gowers WR. Epilepsy and other chronic convulsive diseases: their causes, symptoms and treatment 1901, Old Hickory Bookshop, Brinklow, MD, London.
107. Green R.C., Seyfried T.N. Kindling susceptibility and genetic seizure predisposition in inbred mice. Epilepsia 1991, 32:22-26.
108. Greene A.E., Todorova M.T., Mcgowan R., Seyfried T.N. Caloric restriction inhibits seizure susceptibility in epileptic EL mice by reducing blood glucose. Epilepsia 2001, 42:1371-1378.
109. Greene A.E., Todorova M.T., Seyfried T.N. Perspectives on the metabolic management of epilepsy through dietary reduction of glucose and elevation of ketone bodies. J Neurochem 2003, 86:529-537.
110. Grote S.K., La Spada A.R. Insights into the molecular basis of polyglut-amine neurodegeneration from studies of a spinocerebellar ataxia type 7 mouse model. Cytogenet Genome Res 2003, 100:164-174.
111. Group M.C Classification of progressive myoclonus epilepsies and related disorders. Ann Neurol 1990, 28:113-116.
112. Gu X.Q., Yao H., Haddad G.G. Increased neuronal excitability and seizures in the Na (+) /H (+) exchanger null mutant mouse. Am J Physiol Cell Physiol 2001, 281:C496-C503.
113. Guerrini R., De Lorey T.M., Bonanni P., Moncla A., Dravet C., Suisse G., et al. Cortical myoclonus in Angelman syndrome. Ann Neurol 1996, 40:39-48.
114. Hamburgh M., Vicari E. A study of some physiological mechanisms underlying susceptibility to audiogenic seizures in mice. J Neuropathol Exp Neurol 1960, 19:461-472.
115. Hashimoto K., Fukaya M., Qiao X., Sakimura K., Watanabe M., Kano M. Impairment of AMPA receptor function in cerebellar granule cells of ataxic mutant mouse stargazer. J Neurosci 1999, 19:6027-6036.
116. Heim C., Owens M.J., Plotsky P.M., Nemeroff C.B. The role of early adverse life events in the etiology of depression and posttraumatic stress dis-order. Focus on corticotropin-releasing factor. Ann N Y Acad Sci 1997, 821:194-207.
117. Heisler L.K., Chu H.M., Tecott L.H. Epilepsy and obesity in serotonin 5-HT2C receptor mutant mice. Ann N Y Ac ad Sci 1998, 861:74-78.
118. Heisler L.K., Tecott L.H. Knockout Corner: Neurobehavioural conse-quences of a serotonin 5-HT (2C) receptor gene mutation. Int J Neuropsychopharmcol 1999, 2:67-69.
119. Henry K.R. Audiogenic seizure susceptibility induced in C57BL-6J mice by prior auditory exposure. Science 1967, 158:938-940.
120. Henry K.R. Audiogenic seizure susceptibility induced in C57BL-6J mice by prior auditory exposure. Science 1967, 158:938-940.
121. Henry K.R., Mcginn M.D., Berard D.R., Choie R.A. Effects of neonatal thyroxine, genotype, and noise on the ear and audiogenic seizures. J Comp Physiol Psychol 1981, 95:418-424.
122. Herrup K., Wilczynski S.L. Cerebellar cell degeneration in the leaner mutant mouse. Neuroscience 1982, 7:2185-2196.
123. Hess E.J., Wilson M.C. Tottering and leaner mutations perturb transient developmental expression of tyrosine hydroxylase in embryologically distinct Purkinje cells. Neuron 1991, 6:123-132.
124. Hiramatsu M. Brain monoamine levels and El mouse convulsions. Folia Psychiarica et Neurologica Japonica 1981, 35:261-266.
125. Hiramatsu M., Edamatsu R., Suzuki S., Shimada M., Mori A. Regional excitatory and inhibitory amino acid levels in epileptic El mouse brain. Neurochem Res 1990, 15:821-825.
126. Hiramatsu M, Ogawa K., Kabuto H., Mori A. Reduced uptake and release of 5-hydroxytryptamine and taurine in the cerebral cortex of epileptic El mice. Epilepsy Res 1987, 1:40-45.
127. Homanics G.E., Delorey T.M., Firestone L.L., Quinlan J.J., Handforth A., Harrison N.L., et al. Mice devoid of gamma-aminobutyrate type A receptor beta3 subunit have epilepsy, cleft palate, and hypersensitive behavior. Proc Natl Acad Sci USA 1997, 94:4143-4148.
128. Honavar M., Meldrum B.S. Epilepsy. Greenfield's neuropathology 1997, 931-971. Arnold, London. D.I. Graham, P.L. Lantos (Eds.).
129. Hosford D.A., Wang Y. Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures. Epilepsia 1997, 38:408-414.
130. Humbert S., Dhavan R., Tsai L. p39 activates cdk5 in neurons, and is associated with the actin cytoskeleton. J Cell Sci 2000, 113:975-983. Pt 6.
131. Humbert S., Lanier L.M., Tsai L.H. Synaptic localization of p39 a neuronal activator of cdk5. Neuroreport 2000, 11:2213-2216.
132. Ianzano L., Young E.J., Zhao X.C., Chan E.M., Rodriguez M.T., Torrado M.V., Scherer S.W., Minassian B.A. Loss of function of the cytoplasmic isoform of the protein laforin (EPM2A) causes Lafora progressive myoclonus epilepsy. Hum Mutat 2004, 23:170-176.
133. Iizuka S., Ishige A., Komatsu Y, Matsumiya T., Tsuji M., Takeda H. Effects of Saiko-ka-ryukotsu-borei-to on irritable characteristics in El mice. Methods Find Exp Clin Pharmacol 1998, 20:19-26.
134. Ikemoto A., Bole D.G., Ueda T. Glycolysis and glutamate accumula-tion into synaptic vesicles: role of glyceraldehyde phosphate dehydrogenase and 3-phosphoglycerate kinase. J Biol Chem 2003, 278:5929-5940.
135. Isaacs K.R., Abbott L.C. Cerebellar volume decreases in the tottering mouse are specific to the molecular layer. Brain Res Bull 1995, 36:309-314.
136. Ishida N., Kasamo K., Nakamoto Y, Suzuki J. Epileptic seizure of El mouse initiates at the parietal cortex: depth EEG observation in freely moving condition using buffer amplifier. Brain Res 1993, 608:52-57.
137. Isom L.L. Beta subunits: players in neuronal hyperexcitability?. Novartis Found Symp 2002, 241:124-138. discussion 138-143, 226-132.
138. Isom L.L. The role of sodium channels in cell adhesion. Front Biosci 2002, 7:12-23.
139. Iturian W.B., Fink G.B. Effect of age and condition-test interval (days) on an audio-conditioned convulsive response in CF #1 mice. Dev. Psychobiol. 1968, 1:230-235.
140. Jacobs M.P., Fischbach G.D., Davis M.R., Dichter M.A., Dingledine R., Lowenstein D.H., et al. Future directions for epilepsy research. Neurology 2001, 57:1536-1542.
141. Jenck E, Moreau J.L., Mutel V., Martin J.R. Brain 5-HT1C receptors and antidepressants. Prog Neuropsychopharmacol Biol Psychiatry 1994, 18:563-574.
142. Jiang Y.H., Armstrong D., Albrecht U., Atkins C.M., Noebels J.L., Eichele G., et al. Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53and deficits of contextual learning and long-term potentiation. Neuron 1998, 21:799-811.
143. Jouvenceau A., Eunson L.H., Spauschus A., Ramesh V., Zuberi S.M., Kullmann D.M., Hanna M.G. Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel. Lancet 2001, 358:801-807.
144. Kearney J.A., Plummer N.W, Smith M.R., Kapur J., Cummins T.R., Waxman S.G., et al. A gain-of-function mutation in the sodium chan-nel gene Scn2a results in seizures and behavioral abnormalities. Neuroscience 2001, 102:307-317.
145. Kempermann G., Brandon E.P., Gage F.H. Environmental stimulation of 129/SvJ mice causes increased cell proliferation and neurogenesis in the adult dentate gyrus. Curr Biol 1998, 8:939-942.
146. Kempermann G., Kuhn H.G., Gage F.H. Genetic influence on neuro-genesis in the dentate gyrus of adult mice. Proc Natl Acad Sci USA 1997, 94:10409-10414.
147. Kesavapany S., Amin N., Zheng Y.L., Nijhara R., Jaffe H., Sihag R., et al. p35/cyclin-dependent kinase 5 phosphorylation of ras guanine nucleotide releasing factor 2 (RasGRF2) mediates Rac-dependent extracellular signal-regulated kinase 1/2 activity, altering RasGRF2 and microtubule-associated protein lb distribution in neurons. J Neurosci 2004, 24:4421-4431.
148. Khan Z., Carey J., Park H.J., Lehar M., Lasker D., Jinnah H.A. Abnormal motor behavior and vestibular dysfunction in the stargazer mouse mutant. Neuroscience 2004, 127':785-796.
149. Khan Z., Jinnah H.A. Paroxysmal dyskinesias in the lethargic mouse mutant. J Neurosci 2002, 22:8193-8200.
150. King J.T., Lamotte C.C. El mouse as a model of focal epilepsy: a review. Epilepsia 1989, 30:257-265.
151. Kish S.J. Biochemistry of Parkinson's disease: is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease?. Adv Neurol 2003, 91:39-49.
152. Kishino T., Lalande M., Wagstaff J. UBE3A/E6-AP mutations cause Angelman syndrome. Nat Genet 1997, 15:70-73.
153. Knoll J.H., Nicholls R.D., Magenis R.E., Graham J.M., Lalande M., Latt S.A. Angelman and Prader-Willi syndromes share a common chromosome 15 deletion but differ in parental origin of the deletion. Am J Med Genet 1989, 32:285-290.
154. + channel and rescue of weaver granule cells. Neuron 1996, 16:941-952.
155. Kohsaka M., Hiramatsu M., Mori A. Brain catecholamine concen-trations and convulsions in El mice. Adv Biochem Psychophamacol 1978, 19:389-391.
156. Koskiniemi M. Psychological findings in progressive myoclonus epilepsy without Lafora bodies. Epilepsia 1974, 15:537-545.
157. Koskiniemi M., Donner M., Majuri H., Haltia M., Norio R. Progressive myoclonus epilepsy: a clinical and histopathological study. Acta Neurol Scand 1974, 50:307-332.
158. Koskiniemi M., Toivakka E., Donner M. Progressive myoclonus epilepsy: electroencephalographical findings. Acta Neurol Scand 1974, 50:333-359.
159. Kosobud A.E., Crabbe J.C. Genetic correlations among inbred strain sensitivities to convulsions induced by 9 convulsant drugs. Brain Res 1990, 526:8-16.
160. Kwan P., Brodie M.J. Early identification of refractory epilepsy. N Engl J Med 2000, 342:314-319.
161. Laan L.A., Den Boer A.T., Hennekam R.C., Renier W.O., Brouwer O.F. Angelman syndrome in adulthood. Am J Med Genet 1996, 66:356-360.
162. Laan L.A., Renier W.O., Arts W.F., Buntinx I.M., Vd Bu die;rgt I.J., Stroink H., et al. Evolution of epilepsy and EEG findings in Angelman syndrome. Epilepsia 1997, 38:195-199.
163. Laan L.A., V Haeringen A., Brouwer O.F. Angelman syndrome: a review of clinical and genetic aspects. Clin Neurol Neurosurg 1999, 101:161-170.
164. Lafora G., Gluck B. Beitrag zur histopayjologie der myoklonischen epilesie. Z. Ges Neurol Psychiat 1911, 6:1-14.
165. Lafreniere R.G., Rochefort D.L., Chretien N., Rommens J.M., Cochius J.I., Kalviainen R., et al. Unstable insertion in the 5' flanking region of the cystatin B gene is the most common mutation in progressive myoclonus epilepsy type 1, EPM1. Nat Genet 1997, 15:298-302.
166. Langan Y, Nashef L., Sander J.W. Sudden unexpected death in epilepsy: a series of witnessed deaths. J Neurol Neurosurg Psychiatry 2000, 68:211-213.
167. Lappalainen J., Zhang L., Dean M., Oz M., Ozaki N., Yu D.H., et al. Identification, expression, and pharmacology of a Cys23-Ser23 substitution in the human 5-HT2c receptor gene (HTR2C) . Genomics 1995, 27:274-279.
168. Lazarova M., Bendotti C., Samanin R. Studies on the role of serotonin in different regions of the rat central nervous system on pentylenetetrazol-induced seizures and the effect of di-n-propylacetate. Naunyn Schmiedebergs Arch Pharmacol 1983, 322:147-152.
169. Le Gal La Salle G., Naquet R. Audiogenic seizures evoked in DBA/2 mice induce c-fos oncogene expression into subcortical auditory nuclei. Brain Res 1990, 518:308-312.
170. Leestma J.E., Annegers J.F., Brodie M.J., Brown S., Schraeder P., Siscovick D., et al. Sudden unexplained death in epilepsy: observations from a large clinical development program. Epilepsia 1997, 38:47-55.
171. Legare M.E., Bartlett F.S., Frankel W.N. A major effect QTL determined by multiple genes in epileptic EL mice. Genome Res 2000, 10:42-48. 2nd.
172. Legare M.E., Frankel W.N. Multiple seizure susceptibility genes on chromosome 7 in SWXL-4 congenic mouse strains. Genomics 2000, 70:62-65.
173. Lehesjoki A.E. Molecular background of progressive myoclonus epilepsy. Embo J 2003, 22:3473-3478.
174. + channels. Mol Cells 2003, 15:1-9.
175. + channels. J Biol Chem 1995, 270:28660-28667.
176. Letts V.A., Kang M.G., Mahaffey C.L., Beyer B., Tenbrink H., Campbell K.P., Frankel W.N. Phenotypic heterogeneity in the stargazin allelic series. Mamm Genome 2003, 14:506-513.
177. Letts V.A., Valenzuela A., Kirley J.P., Sweet H.O., Davisson M.T., Frankel W.N. Genetic and physical maps of the stargazer locus on mouse chromosome 15. Genomics 1997, 43:62-68.
178. Levitt P., Noebels J.L. Mutant mouse tottering: selective increase of locus ceruleus axons in a defined single-locus mutation. Proc Natl Acad SciUSA 1981, 78:4630-4634.
179. Lewis S.M., Lee ES., Todorova M., Seyfried T.N., Ueda T. Synaptic vesicle glutamate uptake in epileptic (EL) mice. Neurochem Int 1997, 31:581-585.
180. + channel proteins GIRK1 and GIRK2 and their altered expression in weaver brain. J Neuro sei 1996, 16:7137-7150.
181. Lieuallen K., Pennacchio L.A., Park M., Myers R.M., Lennon G.G. Cystatin B-deficient mice have increased expression of apoptosis and glial activation genes. Hum Mol Genet 2001, 10:1867-1871.
182. Lim K.L., Lim T.M. Molecular mechanisms of neurodegeneration in Parkinson's disease: clues from Mendelian syndromes. IUBMB Life 2003, 55:315-322.
183. Liu W, Seto J., Donovan G., Toth M. Jerky, a protein deficient in a mouse epilepsy model, is associated with translationally inactive mRNA in neurons. J Neurosci 2002, 22:176-182.
184. Liu W, Seto J., Sibille E., Toth M. The RNA binding domain of Jerky consists of tandemly arranged helix-turn-helix/homeodomain-like motifs and binds specific sets of mRNAs. Mol Cell Biol 2003, 23:4083-4093.
185. Lockard J.S. Social primate model of epilepsy. Epilepsy a window to brain mechanisms 1980, 286. Raven Press, New York. J.A. Ward (Ed.).
186. Lombardo A.J., Kuzniecky R., Powers R.E., Brown G.B. Altered brain sodium channel transcript levels in human epilepsy. Brain Res Mol Brain Res 1996, 35:84-90.
187. Loscher W. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the phar-macology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res 2002, 50:105-123.
188. Loscher W. Current status and future directions in the pharmacother-apy
189. Loscher W, Schmidt D. New horizons in the development of antiepileptic drugs. Epilepsy Res 2002, 50:3-16.
190. Lu L., Airey D.C., Williams R.W. Complex trait analysis of the hip-pocampus: mapping and biome acute;trie analysis of two novel gene loci with specific effects on hippocampal structure in mice. J Neurosci 2001, 21:3503-3514.
191. Ma E., Haddad G.G. Expression and localization of Na+/H+ exchangers in rat central nervous system. Neuroscience 1997, 79:591-603.
192. Malcolm S., Clayton-Smith J., Nichols M., Robb S., Webb T., Armour J.A., et al. Uniparental paternal disomy in Angelman's syndrome. Lancet 1991, 337:694-697.
193. Maricich S.M., Soha J., Trenkner E., Herrup K. Failed cell migration and death of purkinje cells and deep nuclear neurons in the weaver cerebellum. J Neurosci 1997, 17:3675-3683.
194. Martin B., Desforges C., Chapouthier G. Comparisons between patterns of convulsions induced by two beta-carbolines in 10 inbred strains of mice. Neurosci Lett 1991, 133:73-76.
195. Mathern W.G., Babb T.L., Armstrong D.L. Hippocampal sclerosis. Epilepsy: a comprehensive textbook 1997, 133-155. Lippincott-Raven Publishers, Philadelphia. J. Engels, T. Pedley (Eds.).
196. Matsumoto A., Kumagai T., Miura K., Miyazaki S., Hayakawa C., Yamanaka T. Epilepsy in Angelman syndrome associated with chro-mosome 15q deletion. Epilepsia 1992, 33:1083-1090.
197. Matsumoto M., Nakagawa T., Inoue T, Nagata E., Tanaka K., Takano H., et al. Ataxia and epileptic seizures in mice lacking type 1 inositol 1,4,5-trisphosphate receptor. Nature 1996, 379:168-171.
198. Matsumoto Y, Hiramatsu M., Mori A. Effects of phenytoin on convul-sions and brain 5-hydroxytryptamine levels of El mice. IRCSMed. Sci. 1983, 11:837.
199. Matsuura T., Sutcliffe J.S., Fang P., Galjaard R.J., Jiang Y.H., Benton C.S., et al. De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nat Genet 1997, 15:74-77.
200. Mattson R.H. Emotional effects on seizure occurrence. Adv Neurol 1991, 55:453-460.
201. Maxson S.C., Cowen J.S. Electroencephalographic correlates of the audiogenic seizure response of inbred mice. Physiol Behav 1976, 16:623-629.
202. Maxson S.C., Fine M.D., Ginsburg B.E., Koniecki D.L. A mutant for spontaneous seizures in C57BL/10Bg mice. Epilepsia 1983, 24:15-24.
203. Maxson S.C., Sze P.Y Electroencephalographic correlates of audiogenic seizures during ethanol withdrawal in mice. Psychopharmacology Berl 1976, 47:17-20.
204. McEnery M.W, Copeland T.D., Vance C.L. Altered expression and assembly of N-type calcium channel alpha IB and beta subunits in epileptic lethargic (lh/lh) mouse. J Biol Chem 1998, 273:21435-21438.
205. McKhann G.M., Wenzel HJ., Robbins C.A., Sosunov A.A., Schwartzkroin P.A. Mouse strain differences in kainic acid sensitivity, seizure behavior, mortality, and hippocampal pathology. Neuroscience 2003, 122:551-561. 2nd.
206. Meisler M.H., Kearney J., Ottman R., Escayg A. Identification of epilepsy genes in human and mouse. Annu Rev Genet 2001, 35:567-588.
207. Meldrum B. Do preclinical seizure models preselect certain adverse effects of antiepileptic drugs. Epilepsy Res 2002, 50:33-40.
208. Merritt H.H., Putnam T.J. Sodium diphenylhydantoinate in the treatment of convulsive disorders. JAMA 1938, 111:1068-1073.
209. Metten P., Belknap J.K., Crabbe J.C. Drug withdrawal convulsions and susceptibility to convulsants after short-term selective breeding for acute ethanol withdrawal. Behav Brain Res 1998, 95:113-122.
210. Minassian B.A. Progressive myoclonus epilepsy with polyglucosan bodies: Lafora disease. Adv Neurol 2002, 89:199-210.
211. Minassian B.A., Andrade D.M., Ianzano L., Young E.J., Chan E., Ackerley C.A., Scherer S.W. Laforin is a cell membrane and endoplasmic reticulum-associated protein tyrosine phosphatase. Ann Neurol 2001, 49:271-275.
212. Minassian B.A., Delorey T.M., Olsen R.W., Philippart M., Bronstein Y., Zhang Q., et al. Angelman syndrome: correlations between epilepsy phenotypes and genotypes. Ann Neurol 1998, 43:485-493.
213. Minassian B.A., Ianzano L., Meloche M., Andermann E., Rouleau G.A., Delgado-Escueta A.V., Scherer S.W. Mutation spectrum and pre-dicted function of laforin in Lafora's progressive myoclonus epilepsy. Neurology 2000, 55:341-346.
214. Minassian B.A., Lee J.R., Herbrick J.A., Huizenga J., Soder S., Mungall A.J., et al. Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nat Genet 1998, 20:171-174.
215. Misawa H., Sherr E.H., Lee D.J., Chetkovich D.M., Tan A., Schreiner C.E., Bredt D.S. Identification of a monogenic locus (jamsl) causing juvenile audiogenic seizures in mice. J Neurosci 2002, 22:10088-10093.
216. Miyakawa T., Yagi T., Taniguchi M., Matsuura H., Tateishi K., Niki H. Enhanced susceptibility of audiogenic seizures in Fyn-kinase deficient mice. Brain Res Mol Brain Res 1995, 28:349-352.
217. Moore T., Hecquet S., Mclellann A., Ville D., Grid D., Picard F., Moulard B., et al. Polymorphism analysis of JRK/JH8, the human homologue of mouse jerky, and description of a rare mutation in a case of CAE evolving to JME. Epilepsy Res 2001, 46:157-167.
218. 2+ channels is associated with the ataxic mouse mutation rolling Nagoya (tg (rol) ). J Neurosci 2000, 20:5654-5662.
219. Morrell M.J. Sexual dysfunction in epilepsy. Epilepsia 1991, 32:S38-S45.
220. Mulley J.C., Scheffer I.E., Petrou S., Berkovic S.F. Channelopathies as a genetic cause of epilepsy. Curr Opin Neurol 2003, 16:171-176.
221. Nadler J.V. Minireview. Kainic acid as a tool for the study of temporal lobe epilepsy. Life Sci 1981, 29:2031-2042.
222. Nakayama J., Fu Y.H., Clark A.M., Nakahara S., Hamano K., Iwasaki N., et al. A nonsense mutation of the MASS1 gene in a family with febrile and afebrile seizures. Ann Neurol 2002, 52:654-657.
223. Nashef L., Walker F., Allen P., Sander J.W, Shorvon S.D., Fish D.R. Apnoea and bradycardia during epileptic seizures: relation to sudden death in epilepsy. J. Neurol Neurosurg Psychiatry 1996, 60:297-300.
224. + channels. Science 1996, 272:1950-1953.
225. Nebert D.W. Pharmacogenetics: an approach to understanding chemical and biologic aspects of cancer. J Natl Cancer Inst 1980, 64:1279-1290.
226. Neugebauer R., Paik M., Hauser WA., Nadel E., Leppik I., Susser M. Stressful life events and seizure frequency in patients with epilepsy. Epilepsia 1994, 35:336-343.
227. Neumann P.E., Collins R.L. Genetic dissection of susceptibility to audiogenic seizures in inbred mice. Proc Natl Acad Sci U S A 1991, 88:5408-5412.
228. Neumann P.E., Collins R.L. Confirmation of the influence of a chromosome 7 locus on susceptibility to audiogenic seizures. Mamm Genome 1992, 3:250-253.
229. Neumann P.E., Seyfried T.N. Mapping of two genes that influence susceptibility to audiogenic seizures in crosses of C57BL/6J and DBA/2J mice. Behav Genet 1990, 20:307-323.
230. Noebels J.L. Mutational analysis of inherited epilepsies. Adv. Neurol 1986, 44:97-113.
231. Noebels J.L. Modeling human epilepsies in mice. Epilepsia 2001, 42(Suppl 5):11-15.
232. Noebels J.L. The biology of epilepsy genes. Annu Rev Neurosci 2003, 26:599-625.
233. Noebels J.L., Qiao X., Bronson R.T., Spencer C., Davisson M.T. Stargazer: a new neurological mutant on chromosome 15 in the mouse with prolonged cortical seizures. Epilepsy Res 1990, 7:129-135.
234. Noebels J.L., Sidman R.L. Inherited epilepsy: spike-wave and focal motor seizures in the mutant mouse tottering. Science 1979, 204:1334-1336.
235. Noel J., Pouyssegur J. Hormonal regulation, pharmacology, and mem-brane sorting of vertebrate Na+/H+ exchanger isoforms. Am J Physiol 1995, 268:C283-C296.
236. Norio R., Koskiniemi M. Progressive myoclonus epilepsy: genetic and nosological aspects with special reference to 107 Finnish patients. Clin Genet 1979, 15:382-398.
237. Opeskin K., Berkovic S.F. Risk factors for sudden unexpected death in epilepsy: a controlled prospective study based on coroners cases. Scizure 2003, 12:456-464.
238. Orlowski J., Grinstein S. Na+/H+ exchangers of mammalian cells. JBiol Chem 1997, 272:22373-22376.
239. Ottman R., Annegers J.F., Hauser W.A., Kurland L.T. Higher risk of seizures in offspring of mothers than of fathers with epilepsy. Am J Hum Genet 1988, 43:257-264.
240. Pacia S.V., Devinsky O. Clozapine-related seizures: experience with 5,629 patients. Neurology 1994, 44:2247-2249.
241. 2+-ATPase activity and audiogenic seizures in mice. J Neurochem 1984, 42:1771-1774.
242. Patil N., Cox D.R., Bhat D., Faham M., Myers R.M., Peterson A.S. A potassium channel mutation in weaver mice implicates membrane excitabil-ity in granule cell differentiation. Nat Genet 1995, 11:126-129.
243. Pearl PL., Gibson K.M. Clinical aspects of the disorders of GABA metabolism in children. Curr Opin Neurol 2004, 17:107-113.
244. Peng J., Wu Z., Wu Y, Hsu M., Stevenson F.F., Boonplueang R., et al. Inhibition of caspases protects cerebellar granule cells of the weaver mouse from apoptosis and improves behavioral phenotype. J Biol Chem 2002, 111:44285-44291.
245. Pennacchio L.A., Bouley D.M., Higgins K.M., Scott M.P., Noebels J.L., Myers R.M. Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice. Nat Genet 1998, 20:251-258.
246. Pennacchio L.A., Lehesjoki A.E., Stone N.E., Willour V.L., Virtaneva K., Miao J.E.D.A., et al. Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science 1996, 111:1731-1734.
247. Peterson S.L. Electroshock. Neuropharmacology methods in epilepsy research 1998, 1-26. CRC Press, Boca Raton, FL. S.L. Peterson, T.E. Albertson (Eds.).
248. Petersson S., Persson A.S., Johansen J.E., Ingvar M., Nilsson J., et al. Truncation of the Shaker-like voltage-gated potassium channel, Kvl.l, causes megencephaly. Eur J Neurosci 2003, 18:3231-3240.
249. Pines J. Cell cycle: reaching for a role for the Cks proteins. Curr Biol 1996, 6:1399-1402.
250. Planells-Cases R., Caprini M., Zhang J., Rockenstein E.M., Rivera R.R., Murre C., et al. Neuronal death and perinatal lethality in voltage-gated sodium channel alpha (II) -deficient mice. Biophys J 2000, 78:2878-2891.
251. Poderycki M.J., Simoes J.M., Todorova M., Neumann P.E., Seyfried T.N. Environmental influences on epilepsy gene mapping in EL mice. /. Neurogenet 1998, 12:67-86.
252. Putney L.K., Denker S.R, Barber D.L. The changing face of the Na+/H+ exchanger, NHE1: structure, regulation, and cellular actions. Annu Rev Pharmacol Toxicol 2002, 42:527-552.
253. Rakic P., Sidman R.L. Organization of cerebellar cortex secondary to deficit of granule cells in weaver mutant mice. J Comp Neurol 1973, 152:133-161.
254. Rakic P., Sidman R.L. Sequence of developmental abnormalities leading to granule cell deficit in cerebellar cortex of weaver mutant mice. J Comp Neurol 1973, 152:103-132.
255. Rakic P., Sidman R.L. Weaver mutant mouse cerebellum: defective neuronal migration secondary to abnormality of Bergmann glia. Proc Natl Acad Sci USA 1973, 10:240-244.
256. Rails K. Auditory sensitivity in mice, Peromyscus and Mus musculus. Anim Behav 1967, 15:123-128.
257. Rea R., Spauschus A., Eunson L.H., Hanna M.G., Kullmann D.M. Variable K (+) channel subunit dysfunction in inherited mutations of KCNA1. J Physiol 2002, 538:5-23.
258. Regesta G., Tanganelli P. Clinical aspects and biological bases of drug-resistant epilepsies. Epilepsy Res 1999, 34:109-122.
259. Rezai Z., Yoon C.H. Abnormal rate of granule cell migration in the cerebellum of quot;Weaver quot; mutant mice. Dev Biol 1972, 29:17-26.
260. Rho J.M., Szot P., Tempel B.L., Schwartzkroin P.A. Developmental seizure susceptibility of kvl.l potassium channel knockout mice. Dev Neurosci 1999, 21:320-327.
261. Rhyu I.J., Abbott L.C., Walker D.B., Sotelo C. An ultrastructural study of granule cell/Purkinje cell synapses in tottering (tg/tg) , leaner (tg (la) /tg (la) ) and compound heterozygous tottering/leaner (tg/tg (la) ) mice. Neuroscience 1999, 90:717-728.
262. Rhyu I.J., Oda S., Uhm C.S., Kim H., Suh Y.S., Abbott L.C. Morphologic investigation of rolling mouse Nagoya (tg (rol) /tg (rol) ) cerebel-lar Purkinje cells: an ataxic mutant, revisited. Neurosci Lett 1999, 266:49-52.
263. Rinne R., Saukko P., Jarvinen M., Lehesjoki A.E. Reduced cystatin B activity correlates with enhanced cathepsin activity in progressive myoclonus epilepsy. Ann Med 2002, 34:380-385.
264. Rise M.L., Frankel W.N., Coffin J.M., Seyfried T.N. Genes for epilepsy mapped in the mouse. Science 1991, 253:669-673.
265. Roffler-Tarlov S., Graybiel A.M. The postnatal development of the dopamine-containing innervation of dorsal and ventral striatum: effects of the weaver gene. J Neurosci 1987, 7:2364-2372.
266. Roffler-Tarlov S., Martin B., Graybiel A.M., Kauer J.S. Cell death in the midbrain of the murine mutation weaver. J Neurosci 1996, 16:1819-1826.
267. Rogawski M.A., Loscher W. The neurobiology of antiepileptic drugs. Nat Rev Neurosci 2004, 5:553-564.
268. 2+-ATPase in brains of seizure prone mice. J Neurochem 1976, 27:1299-1304.
269. Roth B.L., Hanizavareh S.M., Blum A.E. Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophre-nia and other disorders. Psychopharmacology (Berl) 2004, 174:17-24.
270. Sakai M., Austin J., Witmer F., Trueb L. Studies in myoclonus epilepsy (Lafora body form) . II. Polyglucosans in the systemic deposits of myoclonus epilepsy and in corpora amylacea. Neurology 1970, 20:160-176.
271. Sakamoto T, Niki H. Acoustic priming lowers the threshold for elec-trically induced seizures in mice inferior colliculus, but not in the deep layers of superior colliculus. Brain Res 2001, 898:358-363.
272. Sander J.W. The epidemiology of epilepsy revisited. Curr Opin Neurol 2003, 16:165-170.
273. Sarkisian M.R. Overview of the current animal models for human seizure and epileptic disorders. Epilepsy Behav 2001, 2:201-216.
274. Schauwecker P.E. Scizure-induced neuronal death is associated with induction of c-Jun N-terminal kinase and is dependent on genetic background. Brain Res 2000, 884:116-128.
275. Schauwecker P.E. Modulation of cell death by mouse genotype: differen-tial vulnerability to excitatory amino acid-induced lesions. Exp Neurol 2002, 178:219-235.
276. Schauwecker P.E. Genetic basis of kainate-induced excitotoxicity in mice: phenotypic modulation of seizure-induced cell death. Epilepsy Res 2003, 55:201-210.
277. Schauwecker P.E., Williams R.W., Santos J.B. Genetic control of sen-sitivity to hippocampal cell death induced by kainic acid: a quantitative trait loci analysis. J. Comp Neurol 2004, 477:96-107.
278. Scheel H., Tomiuk S., Hof mann K. A common protein interaction domain links two recently identified epilepsy genes. Hum Mol Genet 2002, 11:1757-1762.
279. Scheffer I.E., Berkovic S.F. The genetics of human epilepsy. Trends Pharmacol Sci 2003, 24:428-433.
280. Schlesinger K., Boggan W, Freedman D.X. Genetics of audiogenic seizures. I. Relation to brain serotonin and norepinephrine in mice. Life Sci 1965, 4:2345-2351.
281. Schlesinger K., Boggan W, Freedman D.X. Genetics of audiogenic seizures: II. Effects of pharmacological manipulation of brain serotonin, norepinephrine and gamma-aminobutyric acid. Life Sci 1968, 7:437-447.
282. Schreiber R.A. Ethanol induces a transient susceptibility to audiogenic seizures in weanling C57BL/6J mice. Subst Alcohol Actions Misuse 1982, 3:145-152.
283. Schreiber R.A., Lehmann A., Ginsburg B.E., Fuller J.L. Development of susceptibility to audiogenic seizures in DBA/2J and Rb mice: toward a systematic nomenclature of audiogenic seizure levels. Behav Genet 1980, 10:537-543.
284. Schwartzkroin P.A., Roper S.N., Wenzel H.J. Cortical dysplasia and epilepsy: animal models. Adv Exp Med Biol 2004, 548:145-174.
285. Scotti A.L., Bollag O., Nitsch C. Scizure patterns of Mongolian ger-bils subjected to a prolonged weekly test schedule: evidence for a kindling-like phenomenon in the adult population. Epilepsia 1998, 39:567-576.
286. Segal M.M., Douglas A.F. Late sodium channel openings underlying epileptiform activity are preferentially diminished by the anticonvulsant phenytoin. J Neurophysiol 1997, 11:3021-3034.
287. Seyfried T.N. Convulsive disorders. The mouse in biomedical research 1982, 97-124. Academic Press, New York. J.G. Fox (Ed.).
288. Seyfried T.N. Genetic heterogeneity for the development of audiogenic seizures in mice. Brain Res 1983, 271:325-329.
289. Seyfried T.N., Brigande J.V., Flavin H.J., Frankel W.N., Rise M.L., Wieraszko A. Genetic and biochemical correlates of epilepsy in the EL mouse. Neurosciences 1992, 18:9-20. Suppl. 2.
290. Seyfried T.N., Glaser G.H. Genetic linkage between the AH locus and a major gene that inhibits susceptibility to audiogenic seizures in mice. Genetics 1981, 99:117-126.
291. Seyfried T.N., Glaser G.H., Yu R.K. Cerebral, cerebellar, and brain stem gangliosides in mice susceptible to audiogenic seizures. J. Neurochem 1978, 31:21-27.
292. Seyfried T.N., Glaser G.H., Yu R.K. Genetic analysis of serum thyroxine content and audiogenic seizures in recombinant inbred and congenic strains of mice. Exp Neurol 1984, 83:423-428.
293. Seyfried T.N., Glaser G.H., Yu R.K., Palayoor S.T. Inherited convulsive disorders in mice. Adv Neurol 1986, 44:115-133.
294. Seyfried T.N., Todorova M. Experimental models of epilepsy. The epilepsies: etiologies and prevention 1999, 527-542. Academic Press, New York. P. Kotagal, H.O. Luders (Eds.).
295. Seyfried T.N., Todorova M.T., Poderycki M.J. Experimental models of multifactorial epilepsies: the EL mouse and mice susceptible to audiogenic seizures. Adv Neurol 1999, 79:279-290.
296. Seyfried T.N., Yu R.K., Glaser G.H. Genetic analysis of audiogenic seizure susceptibility in C57BL/6J X DBA/2J recombinant inbred strains of mice. Genetics 1980, 94:701-718.
297. Shannon P., Pennacchio L.A., Houseweart M.K., Minassian B.A., Myers R.M. Neuropathological changes in a mouse model of progressive myoclonus epilepsy: cystatin B deficiency and Unverricht-Lundborg disease. JNeuropathol Exp Neurol 2002, 61:1085-1091.
298. Sharp A.H., Black J.L., 3rd Dubel S.J., Sundarraj S., Shen J.P., Yunker A.M., et al. Biochemical and anatomical evidence for specialized voltage-dependent calcium channel gamma isoform expression in the epileptic and ataxic mouse, stargazer. Neuroscience 2001, 105:599-617.
299. Sherwin A.L. Neuroactive amino acids in focally epileptic human brain: a review. Neurochem Res 1999, 24:1387-1395.
300. Shuttleworth C.W., Connor J.A. Strain-dependent differences in cal-cium signaling predict excitotoxicity in murine hippocampal neurons. J Neurosci 2001, 21:4225-4236.
301. + channel GIRK2. Proc NatlAcad Sci USA 1997, 94:923-927.
302. Simon J.R., Ghetti B. The weaver mutant mouse as a model of nigros-triatal dysfunction. Mol Neurobiol 1994, 9:183-189.
303. Sinkkonen S.T, Homanics G.E., Korpi E.R. Mouse models of Angelman syndrome, a neurodevelopmental disorder, display different brain regional GABA (A) receptor alterations. Neurosci Lett 2003, 340:205-208.
304. Sirven J.I. Classifying seizures and epilepsy: a synopsis. Semin Neurol 2002, 22:237-246.
305. Sisodiya S.M. Surgery for malformations of cortical development causing epilepsy. Brain 2000, 123:1075-1091. Pt 6.
306. Sisodiya S.M., Thorn M., Lin W.R., Bajaj N.R, Cross J.H., Harding B.N. Abnormal expression of cdk5 in focal cortical dysplasia in humans. Neurosci Lett 2002, 328:217-220.
307. Skradski S.L., Clark A.M., Jiang H., White H.S., Fu Y.H., Ptacek L.J. A novel gene causing a mendelian audiogenic mouse epilepsy. Neuron 2001, 31:537-544.
308. Skradski S.L., White H.S., Ptacek L.J. Genetic mapping of a locus (massl) causing audiogenic seizures in mice. Genomics 1998, 49:188-192.
309. Slepkov E., Fliegel L. Structure and function of the NHE1 isoform of the Na+/H+ exchanger. Biochem Cell Biol 2002, 80:499-508.
310. Smart S.L., Lopantsev V., Zhang C.L., Robbins C.A., Wang H., Chiu S.Y., et al. Deletion of the K (V) 1.1 potassium channel causes epilepsy in mice. Neuron 1998, 20:809-819.
311. Smeyne R.J., Goldowitz D. Purkinje cell loss is due to a direct action of the weaver gene in Purkinje cells: evidence from chimeric mice. Brain Res Dev Brain Res 1990, 52:211-218.
312. So EX., Sam M.C., Lagerlund T.L. Postictal central apnea as a cause of SUDEP: evidence from near-SUDEP incident. Epilepsia 2000, 41:1494-1497.
313. Stables J.P, Bertram E.H., White H.S., Coulter D.A., Dichter M.A., Jacobs M.P, et al. Models for epilepsy and epileptogenesis: report from the NIH workshop, Bethesda, Maryland. Epilepsia 2002, 43:1410-1420.
314. Stanfield B.B. Excessive intra-and supragranular mossy fibers in the dentate gyrus of tottering (tg/tg) mice. Brain Res 1989, 480:294-299.
315. Stone N.E., Fan J.B., Willour V., Pennacchio L.A., Warrington J.A., Hu A., et al. Construction of a 750-kb bacterial clone contig and restriction map in the region of human chromosome 21 containing the progressive myoclonus epilepsy gene. Genome Res 1996, 6:218-225.
316. Sugawara T., Tsurubuchi Y., Agarwala K.L., Ito M., Fukuma G., Mazaki-Miyazaki E., et al. A missense mutation of the Na+ channel alpha II subunit gene Na (v) 1.2 in a patient with febrile and afebrile seizures causes channel dysfunction. Proc NatlAcad Sci U S A 2001, 98:6384-6389.
317. Sugaya E., Ishige A., Sekiguchi K., Iizuka S., Ito K., Sugimoto A., et al. Pentylenetetrazol-induced convulsion and effect of anticonvulsants in mutant inbred strain El mice. Epilepsia 1986, 27:354-358.
318. Suzuki J., Kasamo K., Ishida N., Murashima Y.L. Initiation, propaga-tion and generalization of paroxysmal discharges in an epileptic mutant animal. Jpn J Psychiatry Neurol 1991, 45:271-274.
319. Suzuki J., Matsushita M., Nakamoto Y. Histopathological alterations in the hippocampus of an EL mouse. Folia Psychiatr Jpn 1983, 37:362-363.
320. Sweet H.O. Waggler and stargazer are allelic. Mouse Genome 1993, 91:312-313.
321. Swinkels W.A.M., Engelsman M., Kasteleijn-Nolst Trenite D.G.A., Baal M.G., De Haan G.J., Oosting J. Influence of an evacuation in February 1995 in the Netherlands on seizure frequency in patients with epilepsy: a controlled study. Epilepsia 1998, 39:1203-1207.
322. Taylor B.A. Recombinant inbred strains: use in gene mapping. Origins of inbred mice 1978, 423-4438. Academic Press, New York. H.C. Morse (Ed.).
323. Tecott L.H., Sun L.M., Akana S.F., Strack A.M., Lowenstein D.H., Dallman M.F., Julius D. Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature 1995, 374:542-546.
324. Tehrani M.H., Barnes E.M.Jr. Reduced function of gamma-aminobutyric acid A receptors in tottering mouse brain: role of cAMP-dependent protein kinase. Epilepsy Res 1995, 22:13-21.
325. Tehrani M.H., Baumgartner B.J., Liu S.C., Barnes E.M.Jr. Aberrant expression of GABAA receptor subunits in the tottering mouse: an animal model for absence seizures. Epilepsy Res 1997, 28:213-223.
326. Temkin N.R., Davis G.R. Stress as a risk factor for seizures among adults with epilepsy. Epilepsia 1984, 25:450-456.
327. Todorova M.T., Burwell T.J., Seyfried T.N. Environmental risk factors for multifactorial epilepsy in EL mice. Epilepsia 1999, 40:1697-1707.
328. Todorova M.T., Dangler C.A., Drage M.G., Sheppard B.J., Fox J.G., Seyfried T.N. Sexual dysfunction and sudden death in epileptic male EL mice: inheritance and prevention with the ketogenic diet. Epilepsia 2003, 44:25-31.
329. Todorova M.T., Tandon P., Madore R.A., Stafstrom C.E., Seyfried T.N. The ketogenic diet inhibits epileptogenesis in EL mice: a genetic model for idiopathic epilepsy. Epilepsia 2000, 41:933-940.
330. Torrisi L., Sangiorgi E., Russo L., Gurrieri F. Rearrangements of chromosome 15 in epilepsy. Am J Med Genet 2001, 106:125-128.
331. Toth M., Grimsby J., Buzsaki G., Donovan G.P Epileptic seizures caused by inactivation of a novel gene, jerky, related to centromere binding protein-B in transgenic mice. Nat Genet 1995, 11:71-75.
332. Trams E.G., Lauter C.J. Ecto-ATPase deficiency in glia of seizure-prone mice. Nature 1978, 271:270-271.
333. Tsai L.H., Delalle I., Caviness V.S., Chae T., Harlow E. p35is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 1994, 371:419-423.
334. Tsuda H., Ito M., Oguro K., Mutoh K., Shiraishi H., Shirasaka Y, Mikawa H. Age-and seizure-related changes in noradrenaline and dopamine in several brain regions of epileptic El mice. Neurochem Res 1993, 18:111-117.
335. Uchibori M., Saito K., Yokoyama S., Sakamoto Y, Suzuki H., Tsuji T., Suzuki K. Foci identification of spike discharges in the EEGs of sleeping El mice based on the electric field model and wavelet decomposi-tion of multi monopolar derivations. J Neurosci Methods 2002, 117:51-63.
336. Upton N., Stratton S. Recent developments from genetic mouse models of seizures. Curr Opin Pharmacol 2003, 3:19-26.
337. Utsumi K., Yoshida K., Maeda T., Mori M., Tatsumi H. Small scale efficient reproduction of EL mice. Jikken. Dobutsu. 1978, 27:305-309.
338. Van Dellen A., Hannan A.J. Genetic and environmental factors in the pathogenesis of Huntington's disease. Neurogenetics 2004, 5:9-17.
339. Van Der Weyden L., Actams D.J., Bradley A. Tools for targeted manip-ulation of the mouse genome. Physiol Genomics 2002, 11:133-164.
340. Venit E.L., Shepard B.D., Seyfried T.N. Oxyge acute;nation prevents sudden death in seizure-prone mice. Epilepsia 2004, 45:993-996.
341. Verney C., Febvret-Muzerelle A., Gaspar P. Early postnatal changes of the dopaminergic mesencephalic neurons in the weaver mutant mouse. Brain Res Dev Brain Res 1995, 89:115-119.
342. Wagstaff J., Knoll J.H., Fleming J., Kirkness E.F., Martin-Gallardo A., Greenberg F., et al. Localization of the gene encoding the GABAA receptor beta 3 subunit to the Angelman/Prader-Willi region of human chro-mosome 15. Am J Hum Genet 1991, 49:330-337.
343. Wakana S., Sugaya E., Naramoto F., Yokote N., Maruyama C., Jin W, et al. Gene mapping of SEZ group genes and determination of pentylenete-trazol susceptible quantitative trait loci in the mouse chromosome. Brain Res 2000, 857:286-290.
344. Walczak T.S., Leppik I.E., D'amelio M., Rarick J., So E., Ahman P., et al. Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study. Neurology 2001, 56:519-525.
345. Wallace R.H., Wang D.W., Singh R., Scheffer I.E., George A.L., Phillips H.A., et al. Febrile seizures and generalized epilepsy associ-ated with a mutation in the Na+-channel betal subunit gene SCN1B. Nat Genet 1998, 19:366-370.
346. Wang J., Stuckey J.A., Wishart M.J., Dixon J.E. A unique carbohy-drate binding domain targets the lafora disease phosphatase to glycogen. JBiol Chem 2002, 277:2377-2380.
347. Wang T.F., Rosenberg P.A., Guidotti G. Characterization of brain ecto-apyrase: evidence for only one ecto-apyrase (CD39) . gene. Brain Res Mol Brain Res 1997, 47:295-302.
348. Weissbecker K.A., Eiston R.C., Greenberg D., Delgado-Escueta A.V. Genetic epidemiology and the search for epilepsy genes. Adv Neurol 1999, 79:323-340.
349. Wenzel HJ., Robbins C.A., Tsai L.H., Schwartzkroin P.A. Abnormal morphological and functional organization of the hippocampus in a p35mutant model of cortical dysplasia associated with spontaneous seizures. J Neurosci 2001, 21:983-998.
350. White H.S., Wolf H.H., Woodhead J.H., Kupferberg H.J. The National Institutes of Health Anticonvulsant Drug Development Program: screening for efficacy. Adv Neurol 1998, 76:29-39.
351. Wieraszko A., Seyfried T.N. Increased amount of extracellular ATP in stimulated hippocampal slices of seizure prone mice. Neurosci Lett 1989, 106:287-293.
352. Wieraszko A., Seyfried T.N. Influence of audiogenic seizures on synaptic facilitation in mouse hippocampal slices is mediated by N-methyl-D-aspartate receptor. Epilepsia 1993, 34:979-984.
353. Wilder R.M. The effects of ketonemia on the course of epilepsy. Mayo Clin Proc 1921, 2:307-308.
354. Williams R.W., Flaherty L., Threadgill D.W. The math of making mutant mice. Genes Brain Behav 2003, 2:191-200.
355. Willott J.F. Comparison of response properties of inferior colliculus neurons of two inbred mouse strains differing in susceptibility to audiogenic seizures. J Neurophysiol 1981, 45:35-47.
356. Willott J.F., Erway L.C., Archer J.R., Harrison D.E. Genetics of age-related hearing loss in mice. II. Strain differences and effects of caloric restriction on cochlear pathology and evoked response thresholds. Hear Res 1995, 88:143-155.
357. Willott J.F., Henry K.R. Roles of anoxia and noise-induced hearing loss in the postictal refractory period for audiogenic seizures in mice. J Comp Physiol Psychol 1976, 90:373-381.
358. Willow M., Taylor S.M., Catterall W.A., Finnell R.H. Down regula-tion of sodium channels in nerve terminals of spontaneously epileptic mice. Cell Mol Neurobiol 1986, 6:213-220.
359. Wirrell E.C. Natural history of absence epilepsy in children. Can J Neurol Sci 2003, 30:184-188.
360. Xia Y, Zhao P., Xue J., Gu X.Q., Sun X., Yao H., Haddad G.G. Na+ channel expression and neuronal function in the Na+/H+ exchanger 1 null mutant mouse. J. Neurophysiol 2003, 89:229-236.
361. Yan Q.S., Jobe P.C., Dailey J.W. Further evidence of anticonvulsant role for 5-hydroxytryptamine in genetically epilepsy-prone rats. Br J Pharmacol 1995, 115:1314-1318.
362. Yang Y, Beyer B.J., Otto J.F., O'brien T.R, Letts V.A., White H.S., Frankel W.N. Spontaneous deletion of epilepsy gene orthologs in a mutant mouse with a low electroconvulsive threshold. Hum Mol Genet 2003, 12:975-984.
363. Yudkoff M., Daikhin Y, Nissim L, Lazarow A. Ketogenic diet, brain glutamate metabolism and seizure control. Prostaglandins Leukot Essent Fatty Acids 2004, 70:277-285.
364. Yudkoff M., et al. Effects of ketone bodies on astrocyte amino acid metabolism. J Neurochem. 1997, 69:682-692.
365. Zifkin B.C., Andermann F. Epilepsy with reflex seizures. The treat- ment of epilepsy: principles and practices 1993, 614-623. Lea and Febiger, Philadelphia. E. Wyllie (Ed.).
366. Zuberi S.M., Eunson L.H., Spauschus A., De Silva R., Tolmie J., Wood N.W., et al. A novel mutation in the human voltage-gated potassium channel gene (Kvl.l) associates with episodic ataxia type 1 and sometimes with partial epilepsy. Brain 1999, 122:817-825. Pt 5.
367. Zwingman T.A., Neumann P.E., Noebels J.L., Herrup K. Rocker is a new variant of the voltage-dependent calcium channel gene Cacnala. J Neurosci 2001, 21:1169-1178.